Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Asset disposition
Quarterly results
Acq. announced
Appointed director
CC transcript
Accel. buyback
|
|
QUEST DIAGNOSTICS INC (DGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/16/2012 |
8-K
| Investor presentation|
Docs:
|
"Investor Day Presentation, entitled “Our New Quest,” presented by Steve Rusckowski, President and Chief Executive Officer",
"Investor Day Presentation, entitled “Disciplined Capital Deployment,” presented by Bob Hagemann, Senior Vice President and Chief Financial Officer",
"Investor Day Presentation, entitled “Restore Growth,” presented by Everett Cunningham, Senior Vice President, Commercial",
"Investor Day Presentation, entitled “Grow Esoteric Through Disease Focus,” presented by Jay Wohlgemuth, M.D., Senior Vice President, Science and Innovation",
"Investor Day Presentation, entitled “Cancer Diagnostic Solutions,” presented by Jon Cohen, M.D., Senior Vice President and Chief Medical Officer",
"Investor Day Presentation, entitled “Driving Operational Excellence,” presented by John Haydon, Senior Vice President, Operations",
"Quest Diagnostics Details Strategy at 2012 Investor Day -- Increases Invigorate Cost Reduction Goal by $100 Million to $600 Million -- -- Announces 76% Increase in Dividend to $1.20 per Share Annually -- MADISON, N.J., November 16, 2012 – As previously announced, Quest Diagnostics Incorporated , the world’s leading provider of diagnostic information services, will host its Investor Day today, November 16, 2012 in New York City. During the event, Quest Diagnostics executives will share their views of the industry and the company’s strategy and plans to drive shareholder value. Speakers will include Stephen Rusckowski, President and Chief Executive Officer; Robert Hagemann, Senior Vice President and Chief Financial Officer; and several members of the company’s senior management team. As part..." |
|
|
|